Loading...
All Posts By
Blog Author

Drew Fuhrman, MA

Software

Enhancing Precision Medicine Through Technology

Precision Medicine is an exciting field, but it needs help growing and becoming more applicable in a clinical setting. We're evaluating some of the challenges that precision medicine is facing today and how technologies such as AIQ Solutions can help enhance the practice.

Posted on 
Jul 2, 2020
  by
Drew Fuhrman, MA
Read More
Software

The Value Of A Treatment Response Software

It's generally accepted that not all patients respond to the same therapy the same way. New technology is allowing physicians and study principle investigators to understand how different patients respond to a given therapy to improve patient outcomes.

Posted on 
Jun 10, 2020
  by
Drew Fuhrman, MA
Read More
News

AIQ Solutions at ASCO Genitourinary Cancers Symposium

AIQ Solutions will be exhibiting at ASCO Genitourinary Cancers Symposium on February 14th and 15th, 2020, at the Moscone West Building in San Francisco.

Posted on 
Jan 22, 2020
  by
Drew Fuhrman, MA
Read More
News

AIQ Solutions Raises $3.2M in Series A Round

AIQ Solutions raises $3.2M in Series A round to continue development and commercialization of medical software platform

Posted on 
Aug 7, 2019
  by
Drew Fuhrman, MA
Read More
News

AIQ Solutions at BIO 2019

AIQ Solutions has been chosen to present during Startup Stadium at BIO 2019, Wednesday, June 5, 2019.

Posted on 
May 31, 2019
  by
Drew Fuhrman, MA
Read More
News

AIQ Solutions at ASCO 2019

AIQ Solutions has contributed to a poster presentation at the 2019 ASCO Annual Meeting in Chicago, IL, held May 31-June 4, 2019.

Posted on 
May 31, 2019
  by
Drew Fuhrman, MA
Read More

Per the US FDA, AIQ technology is indicated for use in the identification, quantification, and evaluation of Regions of Interest (ROIs) from digital medical images, including PET and CT. Any other applications of AIQ technology are for research purposes only.